Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 9/20 | 0.62 |
| ▸ | RAB9A | P51151 | 5/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.62 |
| ▸ | BLM | P54132 | 3/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | JAK2 | O60674 | 1/20 | 0.62 |
| ▸ | EPHB2 | P29323 | 1/20 | 0.62 |
| ▸ | CDK4 | P11802 | 1/20 | 0.50 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | ABL2 | P42684 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15019989 | 0.86 | DNM1 (0.73) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15022768 | 0.84 | DNM1 (0.71) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL11419341 | 0.84 | DNM1 (0.71) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL11805322 | 0.84 | DNM1 (0.71) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15020045 | 0.83 | DNM1 (0.69) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15039495 | 0.83 | DNM1 (0.69) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15020041 | 0.83 | DNM1 (0.69) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15020366 | 0.78 | DNM1 (0.61) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15039538 | 0.78 | DNM1 (0.61) | DNM1MAPTRAB9AMAPK1BLM | |
| SCHEMBL15039490 | 0.78 | DNM1 (0.61) | DNM1MAPTRAB9AMAPK1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142547-A1 | COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION | ABIVAX (FR) | 2023-05-11 | — | — | US | disclosed |
| EP-4121053-A1 | COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION | ABIVAX (FR) | 2023-01-25 | — | — | EP | disclosed |
| CN-115605205-A | Compounds for treating or preventing infections of the family coronaviridae and methods and uses for assessing the occurrence of infections of the family coronaviridae | ABIVAX公司（FR） | 2023-01-13 | — | — | CN | disclosed |
| WO-2021186053-A1 | COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION | ABIVAX (FR) | 2021-09-23 | — | — | WO | disclosed |
| US-8668821-B2 | Detection of phenols | ISIS INNOVATION LIMITED (GB) | 2014-03-11 | — | — | US | disclosed |
| US-20130098779-A1 | Detection of Phenols | ISIS INNOVATION LIMITED (GB) | 2013-04-25 | — | — | US | disclosed |
| EP-1891423-B1 | DETECTION OF PHENOLS | ISIS INNOVATION (GB) | 2012-02-22 | — | — | EP | disclosed |
| US-20090294298-A1 | Detection of Phenols | ISIS INNOVATION LIMITED (GB) | 2009-12-03 | — | — | US | disclosed |
| EP-1891423-A1 | DETECTION OF PHENOLS | Isis Innovation Limited (GB) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006134386-A1 | DETECTION OF PHENOLS | ISIS INNOVATION LIMITED (GB) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142547-A1 | COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION | ACE, ACE2, SARS1 | DNM1 1018/4885MAPT 1440/4885RAB9A 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.